SAN DIEGO, May 27, 2014 (GLOBE NEWSWIRE) -- Kannaway, LLC, the first hemp lifestyle network marketing company to offer cannabidiol (CBD)-rich hemp botanical products, announced at their Atlanta Conference that product commissions paid totaled nearly $1 million in the company's short 88-day history. Kannaway's rapid growth in the network marketing industry is due to significantly increased hemp awareness and surging popularity of hemp lifestyle products in the U.S. fueled by the ability to provide the world's first bi-bong™ formulations of CBD-rich hemp oil products. From the stage in Atlanta on May 24, executives unveiled the latest product in the Cannabis Beauty DEFINED™ line: CBD-rich hemp oil bi-bong™ herbal capsules.
Photos accompanying this release are available at
"Cannabis Beauty DEFINED™ CBD-rich hemp oil capsules are a very convenient and transportable way to add to one's nutrition on a daily basis," states Kannaway CEO Jeff Rogers. "The bi-bong™ herbal extract includes 'super foods' like gogi berry, burdock root and green tea. The capsules are vegan, soy-free, gluten-free and nut-free. With 60 capsules per bottle and 4mg of CBD from hemp oil in each cap, DEFINED™ provides an innovative new supplement for health-conscious Americans."
The current line of Kannaway's exclusively formulated CBD-rich hemp oil products are:
- Cannabis Beauty DEFINED™ luxury anti-aging cleanser, exfoliant, moisturizer, day & night serum, toner, and salve.
- KannaKick™ functional food energy chews with 10mg of caffeine (slightly more than a cup of coffee) in sour apple, "icy", chocolate, citrus, and cinnamon flavors.
- HempVĀP™ lifestyle vaporizer pen that uses strawberry and honeydew flavored CBD-rich hemp oil.
"We are extremely proud that Kannaway is taking the network marketing industry by storm," Rogers continues. "The explosive growth of 'Kannaway Nation' has exceeded 70,000 marketing professionals since the pre-launch 88 days ago. Paying sales commissions of nearly $1 million in that short amount of time is a clear indication that this is just the beginning of bringing back this versatile plant to our domestic economy. We look forward to continuing mass education of CBD-rich hemp oil lifestyle products and how they have an impact on our everyday lives. We invite the public to join our 'movement with a pay plan.' Our next stop on the Kannaway national tour is Chicago on June 7 at the Chicago Cannabis Conference." Tickets to the event may be purchased at Kannaway.com/Chicago.
Attending the Atlanta Kannaway convention in support of the nationwide introduction of new CBD-rich hemp oil lifestyle products were industry leaders including: Natural News national radio show host Robert Scott Bell; UFC professional athlete Brandon Vera; IFBB Professional Bodybuilder, X-Man Toney Freeman, and Dean Petkanas, CEO of KannaLife Sciences, Inc.
KannaLife is a socially responsible bio-pharmaceutical and phyto-medical company that specializes in the research and development of pharmacological products derived from plants. Kannaway holds a five-year exclusive agreement with KannaLife for product development.
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About KannaLife Sciences, Inc.
KannaLife Sciences, Inc. is a late stage bio-pharmaceutical and phyto-medical company involved in the research and development of novel new therapeutic agents designed as neuroprotectants, immuno-modulators and reduce oxidative stress. KannaLife Sciences currently holds an exclusive license with National Institutes of Health – Office of Technology Transfer ("NIH-OTT") for the commercialization of U.S. Patent 6,630,507, "Cannabinoids as Antioxidants and Neuroprotectants" (the "507 Patent"). KannaLife is currently conducting research and development at the Pennsylvania Biotechnology Center in Doylestown, PA, for a target drug candidate to treat hepatic encephalopathy ("HE"). HE is an oxidative stress-related disease that affects the cognitive and behavioral functions, and the wellness of the brain and the liver. For more information, please visit KannaLife's website at: www.kannalife.com
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Kannaway, LLC to be materially different from the statements made herein.
Kannaway, LLC does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does sell and distribute industrial hemp-based products. Cannabidiol is a natural constituent of hemp oil.
The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.